Retrospective Data Collection of Routine Use With Spectra Optia® for Platelet Depletions

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

12 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-11-30

Study Completion Date

2015-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Multicenter, Retrospective Data Collection of Routine Clinical Use with the Spectra Optia® Apheresis System for Platelet Depletion Procedures.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Data Collection of Routine Clinical Use With the Spectra Optia® Apheresis System for White Blood Cell Depletion

NCT02302365

Leukocytosis

COMPLETED

Efficacy of Ferric Carboxymaltose With or Without EPO Reducing Red-cell Transfusion Packs in Hip Fracture Perioperative Period

NCT01154491

Hip Fractures

COMPLETED PHASE3

Platelet Transfusion Requirements in Hematopoietic Transplantation Pilot Study

NCT02650791

Hematologic Neoplasms

COMPLETED PHASE3

Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage

NCT04149171

Hemorrhagic Shock

COMPLETED PHASE3

Oral and Intravenous Tranexamic Acid in Lumbar Spine Surgery

NCT03037515

Blood Loss, Surgical Blood Loss Anemia

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a multicenter, retrospective data collection to evaluate the in routine use performance and safety of platelet depletions performed via the Spectra Optia system. Data collection will include procedures in 2- 3 different centers in Europe done between November 2011 and April 2014.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Thrombocythemia Myeloproliferative Disease Thrombocytosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Spectra Optia Apheresis System

Platelet Depletion

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients having received a minimum of one platelet depletion procedure via the Spectra Optia system.
* Availability of complete blood count results prior to starting and after completing the platelet depletion procedure via the Spectra Optia system.